Overview

A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2027-10-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate how effective JNJ-77242113 is in participants with generalized pustular psoriasis (GPP) or erythrodermic psoriasis (EP).
Phase:
PHASE3
Details
Lead Sponsor:
Janssen Pharmaceutical K.K.